1,1'-[6-[3-(TRIFLUOROMETHYL)-PHENOXY]-1,3,5-TRIAZINE-2,4-DIYL]-BIS-4-PIPERIDINEMETHANOL
Compound with spectra: 1 NMR
![1,1'-[6-[3-(TRIFLUOROMETHYL)-PHENOXY]-1,3,5-TRIAZINE-2,4-DIYL]-BIS-4-PIPERIDINEMETHANOL](/api/compound/BBqkpYQDxbM.png?ph=true&h=300&w=458 "1,1'-[6-[3-(TRIFLUOROMETHYL)-PHENOXY]-1,3,5-TRIAZINE-2,4-DIYL]-BIS-4-PIPERIDINEMETHANOL")
| SpectraBase Compound ID | BBqkpYQDxbM |
|---|---|
| InChI | InChI=1S/C22H28F3N5O3/c23-22(24,25)17-2-1-3-18(12-17)33-21-27-19(29-8-4-15(13-31)5-9-29)26-20(28-21)30-10-6-16(14-32)7-11-30/h1-3,12,15-16,31-32H,4-11,13-14H2 |
| InChIKey | JTNVBYHYFAYCLF-UHFFFAOYSA-N |
| Mol Weight | 467.49 g/mol |
| Molecular Formula | C22H28F3N5O3 |
| Exact Mass | 467.214424 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
[1-[4,6-BIS-[3-(TRIFLUOROMETHYL)-PHENOXY]-1,3,5-TRIAZIN-2-YL]-PIPERIDIN-4-YL]-METHANOL
3,3'-[1,1'-(6-HEPTYLOXY)-1,3,5-TRIAZINE-2,4-DIYL]-BIS-[(PIPERIDINE-4,1-DIYL)]-DIPHENOL
6-(4-Dimethylamino-6-morpholin-4-yl-[1,3,5]triazin-2-yloxy)-pyridazin-3-ol
N-[4-[chloranyl-bis(fluoranyl)methoxy]phenyl]-4-methoxy-6-morpholin-4-yl-1,3,5-triazin-2-amine
acetic acid, [[4-(1-piperidinyl)-6-[[3-(trifluoromethyl)phenyl]amino]-1,3,5-triazin-2-yl]amino]-, ethyl ester
Benzaldehyde, 2-nitro-, [4-(dipropylamino)-6-methoxy-1,3,5-triazin-2-yl]hydrazone
benzaldehyde, 2,4-dihydroxy-, [4-methoxy-6-(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazone
2-methoxy-1-methyl-2-oxoethyl 4-{[4-(sec-butylamino)-6-(isopropylamino)-1,3,5-triazin-2-yl]oxy}benzoate
4-chloro-6-((4-(dimethylamino)-6-phenoxy-1,3,5-triazin-2-yl)thio)-N,N-dimethyl-1,3,5-triazin-2-amine
N-[4-[[4-(4-acetamidophenoxy)-6-(diphenylamino)-1,3,5-triazin-2-yl]oxy]phenyl]ethanamide
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antiviral Evaluation of Some <i>C</i><sub>3</sub>-Symmetrical Trialkoxy-Substituted 1,3,5-Triazines and Their Molecular Geometry | CHEMICAL & PHARMACEUTICAL BULLETIN | 2015 |